Related Experiment Video
Updated: Feb 27, 2026
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
Selective inhibitors of human mPGES-1 from structure-based computational screening
Ziyuan Zhou1, Yaxia Yuan2, Shuo Zhou1
1Molecular Modeling and Biopharmaceutical Center, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, KY 40536, United States; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, KY 40536, United States.
Researchers identified novel, potent inhibitors for microsomal prostaglandin E synthase-1 (mPGES-1), a key target for anti-inflammatory drugs. This discovery offers new therapeutic strategies for inflammation-related diseases.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Discovery
Background:
- Microsomal prostaglandin E synthase-1 (mPGES-1) is a crucial enzyme in inflammation.
- Current mPGES-1 inhibitors have limited clinical success, necessitating novel therapeutic approaches.
Purpose of the Study:
- To discover and design novel, potent, and selective inhibitors of human mPGES-1.
- To explore new chemical scaffolds for mPGES-1 inhibition.
Main Methods:
- Combined computational modeling and experimental validation.
- Structure-based drug design principles were applied.
Main Results:
- Identification of a series of novel inhibitors with diverse scaffolds.
- Demonstrated potency and selectivity for human mPGES-1.
- Computational models provided insights into inhibitor binding.
Conclusions:
- The identified inhibitors represent promising candidates for next-generation anti-inflammatory drugs.
- The study provides a foundation for rational design of improved mPGES-1 inhibitors.
